Cleared Traditional

K852963 - MYO-ACTUATOR

K852963 is an FDA 510(k) clearance for MYO-ACTUATOR, manufactured by Verimed Holdings, Inc.. The device is a Class 2 Neurology device with product code HCC cleared through the Traditional 510(k) pathway after a 193-day FDA review.

K852963 · Verimed Holdings, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1986
Decision
193d
Days
Class 2
Risk

K852963 is an FDA 510(k) clearance for the MYO-ACTUATOR. Classified as Device, Biofeedback (product code HCC), Class II - Special Controls.

Submitted by Verimed Holdings, Inc. (Fort Lauderdale, US). The FDA issued a Cleared decision on January 21, 1986 after a review of 193 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5050 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Verimed Holdings, Inc. devices

FDA 510(k) Submission Details - K852963

510(k) Number K852963 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 12, 1985
Decision Date January 21, 1986
Days to Decision 193 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
45d slower than avg
Panel avg: 148d · This submission: 193d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HCC Device Classification - Class 2, Special Controls

Product Code HCC Device, Biofeedback
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - HCC Device, Biofeedback

All 55
Devices cleared under the same product code (HCC) and FDA review panel - the closest regulatory comparables to K852963.
MYODAC2 BIOFEEDBACK DEVICE
K894840 · Thought Technology , Ltd. · Oct 1989
MYODAC
K883597 · Thought Technology , Ltd. · Nov 1988
MYOTRAC
K881416 · Thought Technology , Ltd. · Sep 1988
TEMP/SC 200T -SKIN CONDUCTANCE/SKIN TEMP BIOFEEDBA
K850642 · Thought Technology , Ltd. · May 1985
HR/BVP 100T HEART RATE MONITOR
K850643 · Thought Technology , Ltd. · May 1985
CALMTONE
K834519 · Thought Technology , Ltd. · Jan 1984